Pharmaceutical Commerce

JUNE 18, 2025

How Recent Executive Orders Impact the Drug Pricing Landscape Nicholas Saraceno, Editor May 30th 2025 Podcast Alice Valder Curran outlines the steps manufacturers should take to better prepare for upcoming executive actions on drug pricing and market access.

Specialty Pharmacies 52

Specialty Pharmacies Drug Pricing Pharmacy Technician Pharmaceutical Companies 52

Pharmaceutical Commerce

JUNE 16, 2025

24 Hours in the Hub Still Matters More June 16, 2025 By Chris Dowd, ConnectiveRx Commentary Article Pharmaceutical Commerce Pharmaceutical Commerce - June 2025 Volume 20 Issue 3 Doubling down on patient access and support fundamentals will win out over Washington’s next move. Chris Dowd Key Takeaways Speed is Critical.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Commerce

JUNE 18, 2025

June 12, 2025. Accessed June 18, 2025. How the Rise in Self-Injectables Is Impacting Pharmaceutical Manufacturing. Pharmaceutical Commerce. May 6, 2025. Accessed June 18, 2025. February 18, 2025. Accessed June 18, 2025. Robinson S. Suj Mehta Named CEO of TekniPlex Healthcare.

Drug Pricing 52

Drug Pricing Packaging Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Commerce

JUNE 13, 2025

Bill Roth Key Takeaways Price hikes, not launch prices, drove the GTN bubble. The real driver of the gross-to-net (GTN) bubble was the pharmaceutical industry's ability to raise drug prices year after year—enabled by loopholes in PBM contracts—rather than high launch prices alone.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Drug Pricing Pharmaceutical Manufacturing Biosimilars 52

Viseven

MAY 9, 2025

Role of HEOR in Pharmaceutical Industry With budget constraints tightening and drug prices facing greater scrutiny, Health Economics and Outcomes Research has become a cornerstone of modern pharmaceutical strategy. Drug pricing continues to dominate global discussions, ranking as the second major trend.

Drug Pricing 52

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 52

Pharmaceutical Commerce

JUNE 17, 2025

How Recent Executive Orders Impact the Drug Pricing Landscape Nicholas Saraceno, Editor May 30th 2025 Podcast Alice Valder Curran outlines the steps manufacturers should take to better prepare for upcoming executive actions on drug pricing and market access.

Health and Personal Care Stores 52

Health and Personal Care Stores Insurance Coverage and Processing Hospitals Drug Pricing 52

Pharmaceutical Commerce

JUNE 18, 2025

Nicholas Saraceno Key Takeaways DSCSA enforcement deadlines are phasing in through 2025 , with wholesalers and repackagers already required to comply as of May 27, and wholesale distributors facing an August 27 deadline—provided they show active progress on data connections. Nicholas Saraceno is Pharmaceutical Commerce's Editor.

Drug Pricing 52

Drug Pricing Specialty Pharmacies Pharmaceutical Manufacturing Documentation 52

Putting Patients First Blog

MAY 6, 2025

250414-0065, XRIN 0694-XC120] Dear Director Astle: The National Health Council (NHC) appreciates the opportunity to provide comments on the Bureau of Industry and Security’s Section 232 investigation into the national security implications of imports of pharmaceuticals and pharmaceutical ingredients.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Generic Medicine Drug Pricing Hospitals 52

European Pharmaceutical Review

FEBRUARY 20, 2025

Impact on drug pricing and affordability Increased API costs may force some manufacturers to reduce output or exit the market entirely, reducing competition and potentially driving price inflation” Rising production costs due to tariffs could lead to higher drug prices, particularly in markets where pricing pressures are already a concern.

Generic Medicine 20

Generic Medicine Drug Pricing Pharmaceutical Manufacturing Hospitals 20

BioPharma Dive

JUNE 5, 2025

Deep Dive Library Events Press Releases Topics Sign up Search Sign up Search Pharma Biotech FDA Clinical Trials Deals Drug Pricing Gene Therapy An article from FDA’s AI tool ‘Elsa’ is here, and the industry has questions The agency has provided only limited details about its AI pilot as it advances an “aggressive timeline” for the tool’s rollout.

Drug Pricing 52

Drug Pricing Drug Development Vaccines Pharmaceutical Manufacturing 52

FDA Law Blog: Biosimilars

MAY 13, 2025

Wasserstein We are still parsing through the May 12 Executive Order (EO), Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients and impacts this may have on the pharmaceutical industry. Of interest to these bloggers is the provision that deals with personal use importation. (We Please bear with us.)

Online Pharmacies 59

Online Pharmacies Drug Pricing Documentation Pharmaceutical Manufacturing 59

Big Molecule Watch

MAY 15, 2025

In the past month, President Trump signed two executive orders concerning drug access and affordability, including for biologics and biosimilar drugs. On April 15, 2025, President Trump signed Executive Order No. 14273 (EO 273), titled Lowering Drug Prices By Once Again Putting Americans First.

Drug Pricing 59

Drug Pricing Biosimilars Pharmaceutical Manufacturing 59

STAT

MAY 15, 2025

… Roche warned that President Trump’s executive order on drug pricing threatens its planned $50 billion investment in the United States , Reuters writes. Roche said it did not expect the executive order to affect its business in 2025, and that it would continue engaging with the Trump administration and Congress.

Drug Pricing 166

Drug Pricing Pharmaceutical Manufacturing Vaccines 166

Pharmacy Times

JUNE 12, 2025

President Trump Signs Executive Order to Create Most Favored Nations On May 12, 2025, President Donald J. President Trump Signs Executive Order to Create Most Favored Nations On May 12, 2025, President Donald J. 1 The order attempts to set price targets that are equal to or less than those of other “comparably developed nations.”

Pharmacy Technician 26

Pharmacy Technician Community Pharmacies Drug Pricing Hospitals 26

Safe Biologics

MARCH 10, 2025

This expansion continues a flawed policy that threatens innovation and jeopardizes patient access to critical treatments, including drugs vital for cancer treatment and popular new weight loss medications that have transformed the management of obesity and related conditions. PBM Reform: Could 2025 Finally See a Long-Awaited Overhaul?

Biosimilars 130

Biosimilars Independent Pharmacies Drug Pricing Vaccines 130

Pharmacy Times

JUNE 16, 2025

According to Trump, patients could see cost reductions of 30% to 80%, but experts question the feasibility and practicality of implementing such a policy within the complex United States drug pricing and supply system. Kennedy Jr, is permitted to develop a new rule that ties American drug prices to those of other nations.

Pharmacy Technician 26

Pharmacy Technician Drug Pricing Insurance Coverage and Processing Compounding Pharmacies 26